These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 24720286)

  • 1. Cancer stem cells in prostate cancer chemoresistance.
    Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y
    Curr Cancer Drug Targets; 2014; 14(3):225-40. PubMed ID: 24720286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
    Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
    Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
    Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
    Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and prostate cancer stem cells: a novel therapeutic target.
    Mayer MJ; Klotz LH; Venkateswaran V
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cells and Targeting Strategies.
    Barbato L; Bocchetti M; Di Biase A; Regad T
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism.
    Li SS; Ma J; Wong AST
    J Gynecol Oncol; 2018 Mar; 29(2):e32. PubMed ID: 29468856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising tumor-associated antigens for future prostate cancer therapy.
    Li Y; Cozzi PJ; Russell PJ
    Med Res Rev; 2010 Jan; 30(1):67-101. PubMed ID: 19536865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
    Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
    Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
    Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
    EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Products That Target Cancer Stem Cells.
    Moselhy J; Srinivasan S; Ankem MK; Damodaran C
    Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
    Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.